Skandinaviska Enskilda Banken (SEB)’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-120,801
Closed -$1.25M 991
2023
Q3
$1.25M Buy
+120,801
New +$1.15M 0.01% 644
2022
Q3
Sell
-74,200
Closed -$191K 1053
2022
Q2
$191K Buy
74,200
+50,787
+217% +$191K ﹤0.01% 878
2022
Q1
$135K Sell
23,413
-11,621
-33% -$104K ﹤0.01% 913
2021
Q4
$516K Hold
35,034
﹤0.01% 841
2021
Q3
$918K Sell
35,034
-3,391
-9% -$125K 0.01% 801
2021
Q2
$1.92M Buy
38,425
+1,078
+3% +$48.2K 0.01% 678
2021
Q1
$1.72M Buy
37,347
+16,806
+82% +$802K 0.01% 700
2020
Q4
$880K Buy
20,541
+4,940
+32% +$187K 0.01% 834
2020
Q3
$636K Buy
15,601
+15,249
+4,332% +$759K ﹤0.01% 801
2020
Q2
$19K Buy
+352
New +$20.1K ﹤0.01% 1022

Other funds holding TRHC

Skandinaviska Enskilda Banken (SEB)'s TRHC Position: Q4 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 120,801 shares — an estimated $1.25M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TRHC in Q2 2020 and held it in 10 quarters. The position peaked at $1.92M in Q2 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 120,801 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $1.25M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.92M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2023, filed 14 Feb 2024.